Ledyard National Bank Organon & Co. Transaction History

Ledyard National Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$31.66 - $38.9 $192,461 - $236,473	-6,079 Closed	0 $0
Q1 2022 Apr 25, 2022	SELL	$30.45 - $39.36 $33,068 - $42,744	-1,086 Reduced 15.16%	6,079 $212,000
Q4 2021 Jan 31, 2022	SELL	$28.67 - $37.13 $15,596 - $20,198	-544 Reduced 7.06%	7,165 $218,000
Q3 2021 Oct 20, 2021	SELL	$28.63 - $35.64 $13,055 - $16,251	-456 Reduced 5.58%	7,709 $253,000
Q2 2021 Jul 27, 2021	BUY	$28.45 - $38.0 $232,294 - $310,270	8,165 New	8,165 $247,000

795

191M

1.59M

931K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.88B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Ledyard National Bank, based on Form 13F filings with the SEC.

Stay updated on Ledyard National Bank with notifications on news.